Aspiriant LLC raised its position in Ambev S.A. ( NYSE:ABEV – Free Report ) by 34.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
Bob Marten is a journalist who covers financial markets and investment strategies. His articles focus on providing insights and analysis on various stocks, ETFs, and investment opportunities. Bob aims to keep readers informed about the latest trends and developments in the world of finance.